E
Eliane Gluckman
Researcher at University of Paris
Publications - 694
Citations - 48573
Eliane Gluckman is an academic researcher from University of Paris. The author has contributed to research in topics: Transplantation & Bone marrow. The author has an hindex of 112, co-authored 679 publications receiving 46415 citations. Previous affiliations of Eliane Gluckman include Medical College of Wisconsin & Leiden University.
Papers
More filters
Journal ArticleDOI
Sickle SCAN™ (BioMedomics) fulfills analytical conditions for neonatal screening of sickle cell disease.
Thao Nguyen-Khoa,Louis Mine,Bichr Allaf,Jean-Antoine Ribeil,Christelle Rémus,Aurélie Stanislas,Valérie Gauthereau,Sarah Enouz,Jason S. Kim,Xiaoxi Yang,Eliane Gluckman,Jean-Louis Beaudeux,Arnold Munnich,Robert Girot,Marina Cavazzana +14 more
TL;DR: Sickle SCAN™ appears to be an accurate point-of-care method for the identification of newborns with SCD trait and meets the criteria for sickle cell disease NBS programs in endemic countries with poor access to laboratory equipment.
Journal ArticleDOI
Umbilical cord blood versus unrelated donor transplantation in adults with primary refractory or relapsed acute myeloid leukemia: a report from Eurocord, the Acute Leukemia Working Party and the Cord Blood Committee of the Cellular Therapy and Immunobiology Working Party of the EBMT.
Frédéric Baron,Myriam Labopin,Annalisa Ruggeri,Gerhard Ehninger,Fransesca Bonifazi,Matthias Stelljes,Jaime Sanz,Gernot Stuhler,Alberto Bosi,Nicolaus Kröger,Maria Teresa Van Lint,Arnold Ganser,Edouard Forcade,Mohamad Mohty,Eliane Gluckman,Arnon Nagler +15 more
TL;DR: The role of CBT in acute myeloid leukemia (AML) patients with active disease at allogeneic hematopoietic cell transplantation (allo-HCT) remains poorly investigated as mentioned in this paper.
Journal ArticleDOI
Effective graft-versus-leukaemia effect after allogeneic stem cell transplantation using reduced-intensity preparative regimens in Fanconi anaemia patients with myelodysplastic syndrome or acute myeloid leukaemia
Philippe Guardiola,Peter Kurre,Amalia Vlad,Jean Michel Cayuela,Helene Esperou,Agnès Devergie,Patricia Ribaud,Gérard Socié,Patrice Richard,R. Traineau,Rainer Storb,Eliane Gluckman +11 more
TL;DR: Even after transplantation, myeloid malignancies remain associated with a poor outcome in FA, and this argues in favour of early intervention when suitable donors are available.
Journal ArticleDOI
The role of HLA matching in unrelated donor hematopoietic stem cell transplantation for sickle cell disease in Europe.
Eliane Gluckman,Josu de la Fuente,Barbara Cappelli,Graziana Maria Scigliuolo,Fernanda Volt,Karina Tozatto-Maio,Karina Tozatto-Maio,Vanderson Rocha,Mina Tommaso,Farah O'Boyle,Frans J. Smiers,Claudia Bettoni Da Cunha-Riehm,Elisabetta Calore,Sonia Bonanomi,Stelios Graphakos,Anna Paisiou,Michael H. Albert,Annalisa Ruggeri,Marco Zecca,Arjan C. Lankester,Selim Corbacioglu +20 more
TL;DR: Unrelated donor HSCT is a valid option for SCD patients who lack an HLA-identical sibling donor, preferably in the context of clinical trials, indicating that HLA matching is an important donor selection factor in this nonmalignant disease.
Journal ArticleDOI
Outcomes Of Transplantation Using A Various Cell Source In Children With Hurlers Syndrome After Myelo-Ablative Conditioning. An Eurocord-EBMT-CIBMTR Collaborative Study
J.J. Boelens,Mieke Aldenhoven,Duncan Purtill,Mary Eapen,T. DeForr,Rob Wynn,M. Cavazanna-Calvo,Jakub Tolar,Vinod K. Prasad,Maria L. Escolar,Eliane Gluckman,Paul J. Orchard,Paul Veys,Joanne Kurtzberg,Vanderson Rocha +14 more